查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
流式細胞技術市場 - 全球及區域分析：按產品類型、按方法、按應用、按最終用戶、按區域 - 分析與預測（2025-2035）
市場調查報告書
商品編碼
1774228

流式細胞技術市場 - 全球及區域分析：按產品類型、按方法、按應用、按最終用戶、按區域 - 分析與預測（2025-2035）

Flow Cytometry Market - A Global and Regional Analysis: Focus on Offering, Application, Methods, End User, and Regional Analysis - Analysis and Forecast, 2025-2035
出版日期: | 出版商: BIS Research | 英文 184 Pages | 商品交期: 1-5個工作天內

價格

2024年全球流式細胞技術市場規模達到33.925億美元，並呈現強勁的成長軌跡。

預計到2035年，市場規模將達到 73.719億美元，2025年至2035年的年複合成長率為 7.40%。流式細胞技術能夠根據多種參數分析和分類細胞，因此在臨床診斷、藥物開發和研發中發揮著非常重要的作用。

主要市場統計資料
預測期 2025-2035
2025年評估 36.111億美元
2035年的預測 73.719億美元
年複合成長率 7.4%

市場介紹

流式細胞技術是一種強大的分析技術，能夠對懸浮狀態下的單一細胞進行多參數分析，廣泛應用於科學研究、臨床診斷和生物製藥開發。其應用範圍涵蓋免疫表現型分析、細胞週期分析和生物標記檢測，推動了腫瘤學、免疫學和感染疾病研究的需求。隨著頻譜流式細胞技術和高通量系統的進步，由於其在個人化醫療和細胞療法中的應用日益廣泛，以及用於精確細胞分析的精密試劑和軟體的廣泛應用，預計該市場將大幅成長。

地理細分

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲範圍內
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 泰國
    • 新加坡
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他
  • 中東和非洲

流式細胞技術市場的區域分析顯示出多樣化的景象，北美佔據領先市場佔有率，其次是歐洲、亞太地區、拉丁美洲和中東及非洲。北美市場規模在2024年為 14.971億美元，預計在整個預測期內保持主導地位，這歸因於先進的醫療基礎設施、尖端研究工具的快速採用、臨床診斷的優惠償付政策以及癌症患病率的上升等因素。歐洲市場規模在2024年為 9.283億美元，預計將實現穩步成長，這得益於強大的研究基礎設施、成熟的生物技術中心（德國、英國、法國和荷蘭）以及血液學和免疫學臨床效用的提高。亞太地區預計將成為成長最快的地區，2025年至2035年的年複合成長率為 9.04%，這得益於生命科學研究的重大進步、醫療保健投資的增加以及對精準診斷的需求的不斷成長。由於醫療基礎設施的改善和生命科學研究投資的增加，拉丁美洲以及中東和非洲地區也有望展現出良好的成長機會。本區域分析重點介紹了流式細胞技術市場的全球廣度和潛力，每個地區都對其整體成長軌跡做出了獨特的貢獻。

流式細胞技術市場的最新趨勢

  • 2025年 5月，Cytek Biosciences 推出了 Cytek Aurora Evo，這是一款先進的全光譜流式細胞儀，進一步增強了該公司旗艦 Aurora 系統的功能。
  • 2025年5月，Becton, Dickinson and Company推出了全球首款結合先進頻譜與即時細胞成像技術的細胞分析儀。這項創新使研究人員能夠提高流式細胞技術的簡單性和通量，在更多應用中獲得更深入的細胞洞察。
  • 2025年3月，Danaher旗下Beckman Coulter Life Sciences推出了CytoFLEX mosaic Spectral Detection Module，這是業界首個變革頻譜流式細胞技術的模組化解決方案。
  • 2025年2月，Becton, Dickinson and Company宣布計劃剝離其生物科學和診斷解決方案業務，以增強策略重點並提升股東價值。新BD將是一家致力於創新、成長和定向投資的純醫療科技公司，剝離後的各部門將作為獨立的生命科學領導者運作。
  • 2025年 1月，Bio-Rad 實驗室將推出 TrailBlazer Tag 和 StarBright Dye Label Kits，為流式細胞技術和螢光西方墨點法標記抗體提供簡單的方法。

產品/創新策略：流式細胞技術市場分析提供了對不斷發展的研究和臨床需求的洞察，使公司能夠客製化和開發流式細胞技術儀儀器、試劑和軟體解決方案，以滿足特定要求，例如高參數分析、頻譜功能和簡化的臨床診斷工作流程。

成長/行銷策略：本報告將幫助組織實施與學術研究、免疫腫瘤學和感染疾病診斷等關鍵領域以及特定地理機會一致的有針對性的行銷策略，以提高客戶參與並加速採用。

競爭策略：公司可以透過突出目標區域最終用戶高度重視的功能來區分其流式細胞術產品，例如儀器擴充性、易用性、售後服務相容性、流式細胞技術支援以及細胞治療和免疫表現型分析等特殊應用。

全球流式細胞技術市場由三家公司主導：Becton, Dickinson and Company、Danaher Corporation（Beckman Coulter, Inc.）和Thermo Fisher Scientific Inc.，每家公司都提供全面的儀器、試劑和耗材產品組合，這些產品是臨床診斷和高級生物醫學研究的行業基準。 Bio-Rad Laboratories 致力於高解析度流式細胞技術解決方案和創新試劑，鞏固了其在免疫學研究和腫瘤診斷領域的主要企業地位。 Cytek Biosciences, Inc. 憑藉其具有成本效益的高參數系統（如 Cytek Aurora）成為強大的競爭對手，這些系統迅速獲得市場佔有率，尤其是在高級頻譜應用領域。Agilent Technologies, Inc.和Sony Biotechnology, Inc.等區域性公司繼續在頻譜流式細胞技術和客製化細胞分析工具等專業領域進行創新。為了保持成長，市場領導者必須致力於持續的產品創新、擴大其試劑組合以及建立策略合作，以滿足精準醫療和個人化診斷不斷變化的需求。

本報告研究了全球流式細胞技術市場，並透過提供類型、方法、應用、最終用戶、地區和參與市場的公司概況，概述了市場和趨勢。

目錄

執行摘要

第1章 市場：產業展望

  • 流式細胞技術市場，全球市場規模（美元），2024-2035
  • 監管狀況/合規性
    • 美國
    • 歐洲
    • 日本
    • 其他地區

第2章 市場：產業展望

  • 市場動態
    • 趨勢、促進因素、挑戰與機會：現狀與未來影響評估，2024-2035
  • 趨勢
    • 流式細胞技術的持續創新
    • 流式細胞技術公司之間的合作、策略夥伴關係和聯盟日益增多
  • 市場動態
    • 市場促進因素
    • 市場限制
    • 市場機會

第3章 供品種類

  • 產品類型摘要
  • 成長佔有率矩陣
    • 裝置
    • 試劑和耗材
    • 軟體

第4章 方法

  • 方法摘要
  • 成長佔有率矩陣
    • 基於細胞的流式細胞技術
    • 以微珠為基礎的流式細胞技術

第5章 應用

  • 使用摘要
  • 成長佔有率矩陣
    • 臨床應用
    • 調查申請
    • 產業

第6章 最終用戶

  • 最終用戶摘要
  • 成長佔有率矩陣
    • 製藥和生物技術公司
    • 醫院和臨床實驗室
    • 學術研究所
    • 其他

第7章 區域

  • 區域摘要
  • 成長佔有率矩陣
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第8章 市場競爭基準化分析與公司概況

  • 公司產品基準
  • 競爭格局
  • 公司簡介
    • Agilent Technologies, Inc.
    • Becton, Dickinson and Company
    • Bio-Rad Laboratories, Inc.
    • Cytek Biosciences, Inc.
    • Danaher Corporation（Beckman Coulter）
    • Sony Biotechnology Inc.
    • Thermo Fisher Scientific Inc.
    • Sysmex Corporation
    • Merck KGaA
    • Miltenyi Biotec
    • Stratedigm, Inc.
    • Cell Signaling Technology Inc.
    • STEMCELL Technologies
    • Bio-Techne
    • Revvity（BioLegend, Inc）

第9章 調查方法

Product Code: BHL3104SA

This report can be delivered within 1 working day.

Introduction of Flow Cytometry Market

The global flow cytometry market, valued at $3,392.5 million in 2024, is on a robust growth trajectory and is anticipated to reach $7,371.9 million by 2035. This market is expected to expand at a compound annual growth rate (CAGR) of 7.40% between 2025 and 2035. Flow cytometry plays a crucial role in clinical diagnostics, drug development, and research applications, with its ability to analyze and sort cells based on multiple parameters.

KEY MARKET STATISTICS
Forecast Period2025 - 2035
2025 Evaluation$3,611.1 Million
2035 Forecast$7,371.9 Million
CAGR7.4%

Market Introduction

Flow cytometry is a powerful analytical technology enabling multiparametric analysis of individual cells in suspension, widely used in research, clinical diagnostics, and biopharmaceutical development. Its applications span immunophenotyping, cell cycle analysis, and biomarker detection, driving demand across oncology, immunology, and infectious disease research. With advancements in spectral flow cytometry and high-throughput systems, the market is poised for significant growth, supported by increasing adoption in personalized medicine and cell therapy, and the expanding use of sophisticated reagents and software for precise cell analysis.

Regional Segmentation:

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Rest-of-Erope
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
    • Singapore
    • Rest-of-Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest-of-Latin America
  • Middle East & Africa

The regional analysis of the flow cytometry market reveals a diversified landscape, with North America leading in market share, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America, with a market value of $1,497.1 million in 2024, is anticipated to maintain its dominance throughout the forecast period, driven by factors such as advanced healthcare infrastructure, rapid adoption of cutting-edge research tools, favorable reimbursement policies in clinical diagnostics., and increasing prevalence of cancer. Europe, with a market value of $928.3 million in 2024, is expected to witness steady growth propelled by strong research infrastructure, established biotech hubs (Germany, the U.K., France, and the Netherlands), and the increasing clinical utility in hematology and immunology.. Asia-Pacific is expected to emerge as the fastest-growing region with a CAGR of 9.04% from 2025 to 2035, fueled by significant advancements in life sciences research, increasing healthcare investments, and a growing demand for precision diagnostics. Latin America and the Middle East & Africa regions are also expected to show promising growth opportunities, driven by improving healthcare infrastructure and a rising investments in life sciences research. This regional analysis underscores the global scope and potential of the flow cytometry market, with each region contributing uniquely to its overall growth trajectory.

Recent Developments in the Flow Cytometry Market

  • In May 2025, Cytek Biosciences launched the Cytek Aurora Evo, an advanced full-spectrum flow cytometer that builds upon the capabilities of its flagship Aurora system.
  • In May 2025, Becton, Dickinson and Company launched the world's first cell analyzer combining advanced spectral and real-time cell imaging technologies. This innovation enables researchers to gain deeper cellular insights across more applications, with enhanced ease and higher throughput in flow cytometry.
  • In March 2025, Beckman Coulter Life Sciences, a Danaher company, introduced the CytoFLEX mosaic Spectral Detection Module-the industry's first modular solution transforming spectral flow cytometry.
  • In February 2025, Becton, Dickinson and Company announced plans to spin off its Biosciences and Diagnostic Solutions business to sharpen strategic focus and enhance shareholder value. Post-separation, "New BD" will be a pure-play MedTech company focused on innovation, growth, and targeted investments, while the spun-off unit will operate as a standalone life sciences leader.
  • In January 2025, Bio-Rad Laboratories launched its TrailBlazer Tag and StarBright Dye Label Kits, providing an easy way to label antibodies for flow cytometry and fluorescent western blot applications.

How can this report add value to an organization?

Product/Innovation Strategy: The flow cytometry market analysis provides insights into evolving research and clinical needs, enabling organizations to develop customized flow cytometry instruments, reagents, and software solutions that address specific requirements such as high-parameter analysis, spectral capabilities, or streamlined workflows for clinical diagnostics.

Growth/Marketing Strategy: The report helps organizations implement targeted marketing strategies tailored to key segments such as academic research, immuno-oncology, or infectious disease diagnostics and specific regional opportunities, improving customer engagement and accelerating adoption.

Competitive Strategy: Organizations can differentiate their flow cytometry offerings by emphasizing features particularly valued by end-users in target regions, such as instrument scalability, ease of use, reagent compatibility, after-sales support, or specialized applications like cell therapy or immunophenotyping.

Methodology

Key Considerations and Assumptions in Market Engineering and Validation

  • The base year considered for the calculation of the market size is 2024. A historical year analysis has been done for the period FY2021-FY2023. The market size has been estimated for FY2024 and projected for the period FY2025-FY2035.
  • The scope of this report has been carefully derived based on interactions with experts in different companies worldwide.
  • The market contribution of flow cytometry anticipated to be launched in the future has been calculated based on the historical analysis of the solutions.
  • Revenues of the companies have been referenced from their annual reports for FY2023 and FY2024. For private companies, revenues have been estimated based on factors such as inputs obtained from primary research, funding history, market collaborations, and operational history.
  • The market has been mapped based on the available flow cytometry products. This report has considered and profiled all the key companies with significant offerings in this field.
  • The report excludes repair and maintenance services, other flow cytometry-related services, and refurbished instruments from the market sizing and forecast analysis, focusing purely on new product sales and innovations.

Primary Research:

The primary sources involve industry experts in flow cytometry, including the market players offering products and services. Resources such as CEOs, vice presidents, marketing directors, and salespersons have been interviewed to obtain and verify both qualitative and quantitative aspects of this research study.

The key data points taken from the primary sources include:

  • Validation and triangulation of all the numbers and graphs
  • Validation of the report's segmentation and key qualitative findings
  • Understanding the competitive landscape and business model
  • Current and proposed production values of a product by market players
  • Percentage split of individual markets for regional analysis

Secondary Research

Open Sources

  • Certified publications, articles from recognized authors, white papers, directories, and major databases, among others
  • Annual reports, SEC filings, and investor presentations of the leading market players
  • Company websites and detailed study of their product portfolio
  • Gold standard magazines, journals, white papers, press releases, and news articles
  • Paid databases

The key data points taken from the secondary sources include:

  • Segmentations and percentage shares
  • Data for market value
  • Key industry trends of the top players of the market
  • Qualitative insights into various aspects of the market, key trends, and emerging areas of innovation
  • Quantitative data for mathematical and statistical calculations

Key Market Players and Competition Synopsis

The global flow cytometry market is dominated by Becton, Dickinson and Company, Danaher Corporation (Beckman Coulter, Inc.), and Thermo Fisher Scientific Inc., each offering comprehensive portfolios of instruments, reagents, and consumables that set industry benchmarks for clinical diagnostics and advanced biomedical research. Bio-Rad Laboratories, Inc. specializes in high-resolution flow cytometry solutions and innovative reagents, solidifying its position as a key player in immune research and oncology diagnostics. Cytek Biosciences, Inc., with its cost-effective, high-parameter systems like the Cytek Aurora, is rapidly capturing market share, particularly in advanced spectral applications, and emerging as a formidable competitor. Regional players such as Agilent Technologies, Inc. and Sony Biotechnology, Inc. continue to innovate in specialized niches, including spectral flow cytometry and customized cell analysis tools. To sustain growth, market leaders must focus on continuous product innovation, expanding reagent portfolios, and forging strategic collaborations to address the evolving needs of precision medicine and personalized diagnostics.

Some prominent names established in flow cytometry market are:

Becton, Dickinson and Company (BD)

Danaher Corporation (Beckman Coulter, Inc.)

Thermo Fisher Scientific Inc.

Bio-Rad Laboratories, Inc.

Cytek Biosciences

Agilent Technologies, Inc.

Sony Biotechnology, Inc.

Table of Contents

Executive Summary

Scope and Definition

1 Market: Industry Outlook

  • 1.1 Global Flow Cytometry Market, Market Size (US$), 2024-2035
    • 1.1.1 Overview
    • 1.1.2 Key Findings
  • 1.2 Regulatory Landscape/Compliance
    • 1.2.1 U.S.
    • 1.2.2 Europe
    • 1.2.3 Japan
    • 1.2.4 Rest-of-the-World

2 Market: Industry Outlook

  • 2.1 Market Dynamics
    • 2.1.1 Trends, Drivers, Challenges, and Opportunities: Current and Future Impact Assessment, 2024-2035
  • 2.2 Trends
    • 2.2.1 Continuous Technological Innovations in Flow Cytometry
    • 2.2.2 Increasing Collaborations, Strategic Partnerships, and Alliances among Flow Cytometry Players
  • 2.3 Market Dynamics
    • 2.3.1 Market Drivers
      • 2.3.1.1 Rising Cancer Prevalence and the Growing Demand for Advanced Diagnostic Testing
      • 2.3.1.2 Growing Use of Flow Cytometry in Regenerative Medicine
      • 2.3.1.3 Growing Healthcare R&D Spending Fuels Adoption of Flow Cytometry Technologies
    • 2.3.2 Market Restraints
      • 2.3.2.1 High Cost of Acquisition
    • 2.3.3 Market Opportunities
      • 2.3.3.1 Increased Use in Clinical Applications and Infectious Disease Diagnostics

3 Offering Type

  • 3.1 Offering Type Summary
  • 3.2 Growth-Share Matrix
    • 3.2.1 Instruments
      • 3.2.1.1 Platforms
        • 3.2.1.1.1 Conventional Flow Cytometers (Non-Sorting)
        • 3.2.1.1.2 Fluorescence Activated Cell Sorting (FACS)
        • 3.2.1.1.3 Imaging Flow Cytometers
        • 3.2.1.1.4 Spectral Flow Cytometers
        • 3.2.1.1.5 Others
      • 3.2.1.2 Replaceable Components and Accessories
    • 3.2.2 Reagents and Consumables
      • 3.2.2.1 Antibodies
      • 3.2.2.2 Fluorescent Dye
      • 3.2.2.3 Beads
      • 3.2.2.4 Others
    • 3.2.3 Software

4 Method

  • 4.1 Method Summary
  • 4.2 Growth-Share Matrix
    • 4.2.1 Cell-Based Flow Cytometry
    • 4.2.2 Bead-Based Flow Cytometry

5 Application

  • 5.1 Application Summary
  • 5.2 Growth-Share Matrix
    • 5.2.1 Clinical Application
      • 5.2.1.1 Cancer (Solid Tumor)
      • 5.2.1.2 Hematology
      • 5.2.1.3 Autoimmune Diseases
      • 5.2.1.4 Organ Transplantation
      • 5.2.1.5 Others
    • 5.2.2 Research Application
      • 5.2.2.1 Drug Discovery
      • 5.2.2.2 Biomarker Detection
      • 5.2.2.3 In-Vitro Toxicology Testing
      • 5.2.2.4 Stem Cell Research
      • 5.2.2.5 Cell Cycle Analysis
      • 5.2.2.6 Cell Viability
      • 5.2.2.7 Cell Apoptosis
      • 5.2.2.8 Others
    • 5.2.3 Industrial
      • 5.2.3.1 Food and Beverages
      • 5.2.3.2 Water Treatment
      • 5.2.3.3 Microbiology Testing
      • 5.2.3.4 Cosmetics and Personal Care Industry
      • 5.2.3.5 Agriculture and Fermentation Industry
      • 5.2.3.6 Other Industries

6 End User

  • 6.1 End User Summary
  • 6.2 Growth-Share Matrix
    • 6.2.1 Pharmaceutical and Biotechnology Companies
    • 6.2.2 Hospitals and Clinical Testing Laboratories
    • 6.2.3 Academic and Research Institutes
    • 6.2.4 Other Industries

7 Region

  • 7.1 Regional Summary
  • 7.2 Growth-Share Matrix
    • 7.2.1 North America
      • 7.2.1.1 Regional Overview
      • 7.2.1.2 Driving Factors for Market Growth
      • 7.2.1.3 Factors Challenging the Market
      • 7.2.1.4 Funding Initiatives & Grants
      • 7.2.1.5 By Country
        • 7.2.1.5.1 U.S.
        • 7.2.1.5.2 Canada
    • 7.2.2 Europe
      • 7.2.2.1 Regional Overview
      • 7.2.2.2 Driving Factors for Market Growth
      • 7.2.2.3 Factors Challenging the Market
      • 7.2.2.4 Funding Initiatives and Grants
      • 7.2.2.5 By Country
      • 7.2.2.6 U.K.
      • 7.2.2.7 Germany
      • 7.2.2.8 France
      • 7.2.2.9 Italy
      • 7.2.2.10 Spain
      • 7.2.2.11 Rest-of-Europe
    • 7.2.3 Asia-Pacific
      • 7.2.3.1 Regional Overview
      • 7.2.3.2 Driving Factors for Market Growth
      • 7.2.3.3 Factors Challenging the Market
      • 7.2.3.4 By Country
      • 7.2.3.5 China
      • 7.2.3.6 Japan
      • 7.2.3.7 India
      • 7.2.3.8 South Korea
      • 7.2.3.9 Australia
      • 7.2.3.10 Thailand
      • 7.2.3.11 Singapore
      • 7.2.3.12 Rest-of-the-Asia-Pacific
    • 7.2.4 Latin America
      • 7.2.4.1 Regional Overview
      • 7.2.4.2 Driving Factors for Market Growth
      • 7.2.4.3 Factors Challenging the Market
      • 7.2.4.4 By Country
      • 7.2.4.5 Brazil
      • 7.2.4.6 Mexico
      • 7.2.4.7 Argentina
      • 7.2.4.8 Rest-of-Latin America
    • 7.2.5 Middle East and Africa
      • 7.2.5.1 Regional Overview
      • 7.2.5.2 Driving Factors for Market Growth
      • 7.2.5.3 Factors Challenging the Market

8 Markets - Competitive Benchmarking & Company Profiles

  • 8.1 Product Benchmarking By Company
  • 8.2 Competitive Landscape
    • 8.2.1 Key Strategies and Developments by Company
      • 8.2.1.1 Product Launch
      • 8.2.1.2 Partnerships
      • 8.2.1.3 Funding, Business Expansion, and Corporate Restructuring
      • 8.2.1.4 Regulatory Activities
      • 8.2.1.5 Merger and Acquisitions
    • 8.2.2 Company Position Analysis in Flow Cytometry Market
    • 8.2.3 Company Share Analysis in Flow Cytometry Market
  • 8.3 Company Profiles
    • 8.3.1 Agilent Technologies, Inc.
      • 8.3.1.1 Overview
      • 8.3.1.2 Top Products/Product Portfolio
      • 8.3.1.3 Top Competitors
      • 8.3.1.4 Key Strategic Developments
      • 8.3.1.5 Analyst View
      • 8.3.1.6 Financial Analysis
    • 8.3.2 Becton, Dickinson and Company
      • 8.3.2.1 Overview
      • 8.3.2.2 Top Products/Product Portfolio
      • 8.3.2.3 Top Competitors
      • 8.3.2.4 Key Strategic Developments
      • 8.3.2.5 Analyst View
      • 8.3.2.6 Financial Analysis
    • 8.3.3 Bio-Rad Laboratories, Inc.
      • 8.3.3.1 Overview
      • 8.3.3.2 Top Products/Product Portfolio
      • 8.3.3.3 Top Competitors
      • 8.3.3.4 Key Strategic Developments
      • 8.3.3.5 Analyst View
      • 8.3.3.6 Financial Analysis
    • 8.3.4 Cytek Biosciences, Inc.
      • 8.3.4.1 Overview
      • 8.3.4.2 Top Products/Product Portfolio
      • 8.3.4.3 Top Competitors
      • 8.3.4.4 Key Strategic Developments
      • 8.3.4.5 Analyst View
      • 8.3.4.6 Key Personal
    • 8.3.5 Danaher Corporation (Beckman Coulter)
      • 8.3.5.1 Overview
      • 8.3.5.2 Top Products/Product Portfolio
      • 8.3.5.3 Top Competitors
      • 8.3.5.4 Key Strategic Developments
      • 8.3.5.5 Analyst View
      • 8.3.5.6 Financial Analysis
    • 8.3.6 Sony Biotechnology Inc.
      • 8.3.6.1 Overview
      • 8.3.6.2 Top Products/Product Portfolio
      • 8.3.6.3 Top Competitors
      • 8.3.6.4 Key Strategic Developments
      • 8.3.6.5 Analyst View
    • 8.3.7 Thermo Fisher Scientific Inc.
      • 8.3.7.1 Overview
      • 8.3.7.2 Top Products/Product Portfolio
      • 8.3.7.3 Top Competitors
      • 8.3.7.4 Key Strategic Developments
      • 8.3.7.5 Analyst View
      • 8.3.7.6 Financial Analysis
    • 8.3.8 Sysmex Corporation
      • 8.3.8.1 Overview
      • 8.3.8.2 Top Products/Product Portfolio
      • 8.3.8.3 Top Competitors
      • 8.3.8.4 Key Strategic Developments
      • 8.3.8.5 Analyst View
      • 8.3.8.6 Financial Analysis
    • 8.3.9 Merck KGaA
      • 8.3.9.1 Overview
      • 8.3.9.2 Top Products/Product Portfolio
      • 8.3.9.3 Top Competitors
      • 8.3.9.4 Target Customers
      • 8.3.9.5 Key Personal
      • 8.3.9.6 Analyst View
      • 8.3.9.7 Financial Analysis
    • 8.3.10 Miltenyi Biotec
      • 8.3.10.1 Overview
      • 8.3.10.2 Top Products/Product Portfolio
      • 8.3.10.3 Top Competitors
      • 8.3.10.4 Target Customers
      • 8.3.10.5 Key Personal
      • 8.3.10.6 Analyst View
      • 8.3.10.7 Financial Analysis
    • 8.3.11 Stratedigm, Inc.
      • 8.3.11.1 Overview
      • 8.3.11.2 Top Products/Product Portfolio
      • 8.3.11.3 Top Competitors
      • 8.3.11.4 Target Customers
      • 8.3.11.5 Key Personal
      • 8.3.11.6 Analyst View
    • 8.3.12 Cell Signaling Technology Inc.
      • 8.3.12.1 Overview
      • 8.3.12.2 Top Products/Product Portfolio
      • 8.3.12.3 Top Competitors
      • 8.3.12.4 Target Customers
      • 8.3.12.5 Key Personal
      • 8.3.12.6 Analyst View
    • 8.3.13 STEMCELL Technologies
      • 8.3.13.1 Overview
      • 8.3.13.2 Top Products/Product Portfolio
      • 8.3.13.3 Top Competitors
      • 8.3.13.4 Target Customers
      • 8.3.13.5 Key Personal
      • 8.3.13.6 Analyst View
    • 8.3.14 Bio-Techne
      • 8.3.14.1 Overview
      • 8.3.14.2 Top Products/Product Portfolio
      • 8.3.14.3 Top Competitors
      • 8.3.14.4 Target Customers
      • 8.3.14.5 Key Personal
      • 8.3.14.6 Analyst View
      • 8.3.14.7 Financial Analysis
    • 8.3.15 Revvity (BioLegend, Inc)
      • 8.3.15.1 Overview
      • 8.3.15.2 Top Products/Product Portfolio
      • 8.3.15.3 Top Competitors
      • 8.3.15.4 Target Customers
      • 8.3.15.5 Key Personal
      • 8.3.15.6 Analyst View
      • 8.3.15.7 Financial Analysis

9 Research Methodology

  • 9.1 Data Sources
    • 9.1.1 Primary Data Sources
    • 9.1.2 Secondary Data Sources
    • 9.1.3 Data Triangulation
  • 9.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Flow Cytometry Market (by Scenario), $Million, 2025 2030, and 2035
  • Figure 2: Global Market Snapshot, 2024
  • Figure 3: Global Flow Cytometry Market, $Million, 2024 and 2035
  • Figure 4: Flow Cytometry Market (by Offering), $Million, 2024, 2030, and 2035
  • Figure 5: Flow Cytometry Market (by Application), $Million, 2024, 2030, and 2035
  • Figure 6: Flow Cytometry Market (by Technology), $Million, 2024, 2030, and 2035
  • Figure 7: Flow Cytometry Market (by End User), $Million, 2024, 2030, and 2035
  • Figure 8: Global Flow Cytometry Market Segmentation
  • Figure 9: Global Flow Cytometry Market, Market Size ($Million), 2024-2035
  • Figure 10: Incidence of Cancer (by Region), Million, 2022, 2025, 2030, 2040, and 2050
  • Figure 11: Key Drivers for Flow Cytometry's Role in Regenerative Medicine:
  • Figure 12: Healthcare R&D Spending, $Billion, 2020-2023
  • Figure 13: Key Applications in Infectious Disease Diagnostics
  • Figure 14: Global Flow Cytometry Market (by Offering Type), $Million, 2024, 2030, and 2035
  • Figure 15: Growth-Share Analysis for Global Flow Cytometry Market (by Offering), 2024-2035
  • Figure 16: Global Flow Cytometry Market (by Offering Type, Instruments), $Million, 2024-2035
  • Figure 17: Global Flow Cytometry Market (by Offering Type, Platforms), $Million, 2024-2035
  • Figure 18: Global Flow Cytometry Market (by Platform, Conventional Flow Cytometers), $Million, 2024-2035
  • Figure 19: Global Sorting FACS Flow Cytometers Market, Value, $Million, 2024-2035
  • Figure 20: Global Sorting FACS Flow Cytometers Market, Volume, Units, 2024-2035
  • Figure 21: Global Non-Sorting FACS Flow Cytometers Market, Value, $Million, 2024-2035
  • Figure 22: Global Non-Sorting FACS Flow Cytometers Market, Volume, Units, 2024-2035
  • Figure 23: Global Sorting Imaging Flow Cytometers Market, Value, $Million, 2024-2035
  • Figure 24: Global Sorting Imaging Flow Cytometers Market, Volume, Units, 2024-2035
  • Figure 25: Global Non-Sorting Imaging Flow Cytometers Market, Value $Million, 2024-2035
  • Figure 26: Global Non-Sorting Imaging Flow Cytometers Market, Volume Units, 2024-2035
  • Figure 27: Global Sorting Spectral Flow Cytometers Market, Value $Million, 2024-2035
  • Figure 28: Global Sorting Spectral Flow Cytometers Market, Volume Units, 2024-2035
  • Figure 29: Global Non-Sorting Spectral Flow Cytometers Market, Value, $Million, 2024-2035
  • Figure 30: Global Non-Sorting Spectral Flow Cytometers Market, Volume, Units, 2024-2035
  • Figure 31: Global Flow Cytometry Market (by Platform, Others), $Million, 2024-2035
  • Figure 32: Global Flow Cytometry Market (by Instruments, Replaceable Components and Accessories), $Million, 2024-2035
  • Figure 33: Global Flow Cytometry Market (by Offering Type, Reagents and Consumables), $Million, 2024, 2030, and 2035
  • Figure 34: Global Flow Cytometry Market (by Reagents and Consumables, Antibodies), $Million, 2024-2035
  • Figure 35: Global Flow Cytometry Market (by Reagents and Consumables, Fluorescent Dye), $Million, 2024-2035
  • Figure 36: Global Flow Cytometry Market (by Reagents and Consumables, Beads), $Million, 2024-2035
  • Figure 37: Global Flow Cytometry Market (by Reagents and Consumables, Others), $Million, 2024-2035
  • Figure 38: Global Flow Cytometry Market (by Offering Type, Software), $Million, 2024-2035
  • Figure 39: Global Flow Cytometry Market (by Method), $Million, 2024, 2030, and 2035
  • Figure 40: Growth-Share Analysis for Global Flow Cytometry Market (by Method), 2024-2035
  • Figure 41: Global Flow Cytometry Market (by Method, Cell-Based Flow Cytometry), $Million, 2024-2035
  • Figure 42: Global Flow Cytometry Market (by Method, Bead-Based Flow Cytometry), $Million, 2024-2035
  • Figure 43: Global Flow Cytometry Market (by Application), $Million, 2024, 2030, and 2035
  • Figure 44: Growth-Share Analysis for Global Flow Cytometry Market (by Application), 2024-2035
  • Figure 45: Global Flow Cytometry Market (by Application, Clinical Application), $Million, 2024-2035
  • Figure 46: Global Flow Cytometry Market (by Clinical Application, Cancer (Solid Tumor)), $Million, 2024-2035
  • Figure 47: Global Flow Cytometry Market (by Clinical Application, Hematology), $Million, 2024-2035
  • Figure 48: Global Flow Cytometry Market (by Clinical Application, Autoimmune Diseases), $Million, 2024-2035
  • Figure 49: Global Flow Cytometry Market (by Clinical Application, Organ Transplantation), $Million, 2024-2035
  • Figure 50: Global Flow Cytometry Market (by Clinical Application, Others), $Million, 2024-2035
  • Figure 51: Global Flow Cytometry Market (by Application, Research Application), $Million, 2024, 2030, and 2035
  • Figure 52: Global Flow Cytometry Market (by Research Application, Drug Discovery), $Million, 2024-2035
  • Figure 53: Global Flow Cytometry Market (by Research Application, Biomarker Detection), $Million, 2024-2035
  • Figure 54: Global Flow Cytometry Market (by Research Application, In-Vitro Toxicology Testing), $Million, 2024-2035
  • Figure 55: Global Flow Cytometry Market (by Research Application, Stem Cell Research), $Million, 2024-2035
  • Figure 56: Global Flow Cytometry Market (by Research Application, Cell Cycle Analysis), $Million, 2024-2035
  • Figure 57: Global Flow Cytometry Market (by Research Application, Cell Viability), $Million, 2024-2035
  • Figure 58: Global Flow Cytometry Market (by Research Application, Cell Apoptosis), $Million, 2024-2035
  • Figure 59: Global Flow Cytometry Market (by Research Application, Others), $Million, 2024-2035
  • Figure 60: Global Flow Cytometry Market (by Application, Industrial), $Million, 2024, 2030, and 2035
  • Figure 61: Global Flow Cytometry Market (by Industrial, Food and Beverages), $Million, 2024-2035
  • Figure 62: Global Flow Cytometry Market (by Industrial, Water Treatment), $Million, 2024-2035
  • Figure 63: Global Flow Cytometry Market (by Industrial, Microbiology Testing), $Million, 2024-2035
  • Figure 64: Global Flow Cytometry Market (by Industrial, Cosmetics and Personal Care Industry), $Million, 2024-2035
  • Figure 65: Global Flow Cytometry Market (by Industrial, Agriculture and Fermentation Industry), $Million, 2024-2035
  • Figure 66: Global Flow Cytometry Market (by Industrial, Other Industries), $Million, 2024-2035
  • Figure 67: Global Flow Cytometry Market (by End User), $Million, 2024, 2030, and 2035
  • Figure 68: Growth-Share Analysis for Global Flow Cytometry Market (by End User), 2024-2035
  • Figure 69: Global Flow Cytometry Market (by End User, Pharmaceutical and Biotechnology Companies), $Million, 2024-2035
  • Figure 70: Global Flow Cytometry Market (by End User, Hospitals and Clinical Testing Laboratories), $Million, 2024-2035
  • Figure 71: Global Flow Cytometry Market (by End User, Academic and Research Institutes), $Million, 2024-2035
  • Figure 72: Global Flow Cytometry Market (by End User, Other Industries), $Million, 2024-2035
  • Figure 73: Growth-Share Analysis for Global Flow Cytometry Market (by Region), 2024-2035
  • Figure 74: North America Flow Cytometry Market, $Million, 2024-2035
  • Figure 75: U.S. Flow Cytometry Market, $Million, 2024-2035
  • Figure 76: Canada Flow Cytometry Market, $Million, 2024-2035
  • Figure 77: Europe Flow Cytometry Market, $Million, 2024-2035
  • Figure 78: U.K. Flow Cytometry Market, $Million, 2024-2035
  • Figure 79: Germany Flow Cytometry Market, $Million, 2024-2035
  • Figure 80: France Flow Cytometry Market, $Million, 2024-2035
  • Figure 81: Italy. Flow Cytometry Market, $Million, 2024-2035
  • Figure 82: Spain Flow Cytometry Market, $Million, 2024-2035
  • Figure 83: Rest-of-Europe Flow Cytometry Market, $Million, 2024-2035
  • Figure 84: Asia-Pacific Flow Cytometry Market, $Million, 2024-2035
  • Figure 85: China Flow Cytometry Market, $Million, 2024-2035
  • Figure 86: Japan Flow Cytometry Market, $Million, 2024-2035
  • Figure 87: India Flow Cytometry Market, $Million, 2024-2035
  • Figure 88: South Korea Flow Cytometry Market, $Million, 2024-2035
  • Figure 89: Australia Flow Cytometry Market, $Million, 2024-2035
  • Figure 90: Thailand Flow Cytometry Market, $Million, 2024-2035
  • Figure 91: Singapore Flow Cytometry Market, $Million, 2024-2035
  • Figure 92: Rest of Asia-Pacific Flow Cytometry Market, $Million, 2024-2035
  • Figure 93: Latin America Flow Cytometry Market, $Million, 2024-2035
  • Figure 94: Brazil Flow Cytometry Market, $Million, 2024-2035
  • Figure 95: Mexico Flow Cytometry Market, $Million, 2024-2035
  • Figure 96: Argentina Flow Cytometry Market, $Million, 2024-2035
  • Figure 97: Rest-of-Latin America Flow Cytometry Market, $Million, 2024-2035
  • Figure 98: Middle East and Africa Flow Cytometry Market, $Million, 2024-2035
  • Figure 99: Global Flow Cytometry Market, Product Benchmarking (by Company)
  • Figure 100: Share of Key Strategies and Developments in Global Flow Cytometry Market, January 2020-May 2025
  • Figure 101: Key Strategies and Developments in Global Flow Cytometry Market by Company, January 2020-May 2025
  • Figure 102: Global Flow Cytometry Market: Company Position Analysis (2024)
  • Figure 103: Global Flow Cytometry Market: Company Share Analysis (2024)
  • Figure 104: Data Triangulation
  • Figure 105: Top-Down and Bottom-Up Approach
  • Figure 106: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Recent Technological Innovations in Flow Cytometry
  • Table 3: Recent Strategic Activities Among Flow Cytometry Players
  • Table 4: Flow Cytometry Instruments and Reagents in Regenerative Medicine
  • Table 5: Price Comparison of Flow Cytometers
  • Table 6: Key Flow Cytometry Platforms
  • Table 7: Global Fluorescence Activated Cell Sorting (FACS) Flow Cytometry Market, Value, $Million, 2024-2035
  • Table 8: Global Fluorescence Activated Cell Sorting (FACS) Flow Cytometry Market, Volume, Units, 2024-2035
  • Table 9: Key Sorting FACS Flow Cytometers in the Market
  • Table 10: Key Non-Sorting FACS Flow Cytometers in the Market
  • Table 11: Global Imaging Flow Cytometers Market, Value, $Million, 2024-2035
  • Table 12: Global Imaging Flow Cytometers Market, Volume, Units, 2024-2035
  • Table 13: Key Sorting Imaging Flow Cytometers in the Market
  • Table 14: Key Non-Sorting Imaging Flow Cytometers in the Market
  • Table 15: Global Spectral Flow Cytometers Market, Value, $Million, 2024-2035
  • Table 16: Global Spectral Flow Cytometers Market, Volume, Units, 2024-2035
  • Table 17: Key Sorting Spectral Flow Cytometers in the Market
  • Table 18: Key Non-Sorting Spectral Flow Cytometers in the Market
  • Table 19: Key Flow Cytometer Software
  • Table 20: Industrial Application Products in Flow Cytometry
  • Table 21: Global Flow Cytometry Market (by Region), $Million, 2024-2035
  • Table 22: Major Grants Supporting Flow Cytometry Innovation and Access (North America and Global)
  • Table 23: North America Flow Cytometry Market (by Country), $Million, 2024-2035
  • Table 24: Europe Flow Cytometry Market (by Country), $Million, 2024-2035
  • Table 25: Asia-Pacific Flow Cytometry Market (by Country), $Million, 2024-2035
  • Table 26: Latin America Flow Cytometry Market (By Country), $Million, 2024-2035